Ziff Davis Quarterly Report: Q1 2025

Key insights

7 takeaways · ~3 min read

01
Ziff Davis reported a significant increase in revenue for Q1 2025, with $84.1 million, up from $74.1 million in Q1 2024, previously included in deferred revenue.
02
The company recognized $6.6 million in income from its equity method investment in OCV Fund for Q1 2025, a substantial improvement from a $(0.6) million loss in Q1 2024.
03
Ziff Davis's equity method investment in OCV Fund increased in carrying value and maximum exposure to approximately $123.6 million as of March 31, 2025, up from $115.0 million at December 31, 2024.
04
Share-based compensation expense increased to $9.752 million in Q1 2025 from $8.872 million in Q1 2024, with a notable rise in general, administrative, and other related costs.
05
Ziff Davis sold its minority interest in OpenEvidence for approximately $30 million on April 24, 2025, receiving a combination of cash and the majority of its common stock shares issued in the initial transaction.
06
The company granted 641,935 restricted stock units (RSUs) in Q1 2025, an increase from 347,275 RSUs granted in Q1 2024.
07
Ziff Davis amended its Credit Agreement on June 18, 2024, increasing the Aggregate Revolving Loan Commitment by $250.0 million to a total of $350.0 million and extending the maturity date to June 18, 2027.